Total Payments
$5,284
2024 Payments
$17.28
Companies
19
Transactions
67
Medicare Patients
11,865
Medicare Billing
$962,946
Payment Breakdown by Category
Consulting$3,000 (56.8%)
Food & Beverage$1,896 (35.9%)
Travel$388.06 (7.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,000 | 1 | 56.8% |
| Food and Beverage | $1,896 | 64 | 35.9% |
| Travel and Lodging | $388.06 | 2 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $3,598 | 11 | $0 (2023) |
| ABBVIE INC. | $335.28 | 11 | $0 (2022) |
| Allergan Inc. | $259.12 | 9 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $205.78 | 6 | $0 (2023) |
| PFIZER INC. | $201.78 | 5 | $0 (2023) |
| Lilly USA, LLC | $194.06 | 8 | $0 (2023) |
| Merz North America, Inc. | $149.23 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $67.32 | 3 | $0 (2023) |
| Amgen Inc. | $48.79 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $35.28 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.28 | 1 | Amgen Inc. ($17.28) |
| 2023 | $375.09 | 15 | Lilly USA, LLC ($137.23) |
| 2022 | $589.72 | 22 | PFIZER INC. ($128.05) |
| 2021 | $73.85 | 5 | Janssen Biotech, Inc. ($32.20) |
| 2020 | $48.30 | 3 | AbbVie Inc. ($30.75) |
| 2019 | $336.16 | 3 | Merz North America, Inc. ($149.23) |
| 2018 | $78.81 | 3 | AbbVie, Inc. ($68.10) |
| 2017 | $3,765 | 15 | Janssen Biotech, Inc. ($3,517) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Inflammation | ||||||
| 12/21/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Immunology | ||||||
| 12/21/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: Immunology | ||||||
| 11/16/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Dermatology | ||||||
| 11/09/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $113.53 | General |
| Category: Immunology | ||||||
| 08/03/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: DERMATOLOGY | ||||||
| 08/03/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Dermatology | ||||||
| 07/11/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: Inflammation | ||||||
| 06/19/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Immunology | ||||||
| 06/06/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Immunology | ||||||
| 05/16/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.47 | General |
| Category: Immunology | ||||||
| 05/11/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Immunology | ||||||
| 03/09/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.32 | General |
| 02/23/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Dermatology | ||||||
| 01/23/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.01 | General |
| 01/13/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $57.95 | General |
| Category: Inflammation & Immunology | ||||||
| 12/14/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.84 | General |
| Category: Immunology | ||||||
| 11/29/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Immunology | ||||||
| 11/03/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.32 | General |
| Category: Dermatology | ||||||
| 09/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: DERMATOLOGY | ||||||
| 08/03/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Immunology | ||||||
| 07/19/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,379 | 3,682 | $502,040 | $208,602 |
| 2022 | 21 | 1,965 | 2,643 | $347,045 | $150,249 |
| 2021 | 33 | 3,758 | 6,544 | $786,701 | $303,372 |
| 2020 | 35 | 3,763 | 6,582 | $775,951 | $300,722 |
Total Patients
11,865
Total Services
19,451
Medicare Billing
$962,946
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 435 | 587 | $82,210 | $37,068 | 45.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 260 | 323 | $51,680 | $21,944 | 42.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 288 | 288 | $48,960 | $19,520 | 39.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 69 | 85 | $45,900 | $19,135 | 41.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 179 | 206 | $36,050 | $16,875 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 165 | $33,000 | $15,577 | 47.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 290 | 382 | $38,200 | $15,285 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $26,400 | $9,144 | 34.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 23 | 29 | $17,400 | $8,884 | 51.1% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 23 | 29 | $13,050 | $5,615 | 43.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 50 | 57 | $25,365 | $5,538 | 21.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 216 | 1,072 | $10,720 | $5,302 | 49.5% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 17 | 18 | $8,640 | $4,318 | 50.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 76 | 80 | $6,800 | $3,213 | 47.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 23 | $6,325 | $3,115 | 49.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 27 | 28 | $12,040 | $2,963 | 24.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 26 | 29 | $6,670 | $2,934 | 44.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 12 | 12 | $5,820 | $2,736 | 47.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 57 | 74 | $6,290 | $2,710 | 43.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 48 | 48 | $5,280 | $2,140 | 40.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 19 | $3,800 | $1,777 | 46.8% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $5,810 | $1,508 | 26.0% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $4,680 | $1,221 | 26.1% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 14 | 14 | $950.00 | $79.94 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 378 | 451 | $63,049 | $30,422 | 48.3% |
About Dr. Stephen Flax, M.D
Dr. Stephen Flax, M.D is a Dermatopathology healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376514596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Flax, M.D has received a total of $5,284 in payments from pharmaceutical and medical device companies, with $17.28 received in 2024. These payments were reported across 67 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($3,000).
As a Medicare-enrolled provider, Flax has provided services to 11,865 Medicare beneficiaries, totaling 19,451 services with total Medicare billing of $962,946. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Clinical & Laboratory Dermatological Immunology, Procedural Dermatology
- Location Winchester, VA
- Active Since 01/27/2006
- Last Updated 08/26/2019
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1376514596
Products in Payments
- Humira (Biological) $186.30
- SKYRIZI (Biological) $132.64
- OLUMIANT (Drug) $113.53
- COSENTYX (Biological) $110.37
- TALTZ (Drug) $80.53
- TREMFYA (Drug) $63.74
- DUPIXENT (Biological) $63.59
- ACZONE (Drug) $58.80
- CIBINQO (Drug) $57.95
- Sotyktu (Drug) $49.31
- RHOFADE (Drug) $48.10
- EUCRISA (Drug) $39.12
- COSENTYX (Drug) $36.40
- Enbrel (Biological) $31.51
- Cimzia (Drug) $23.76
- VTAMA (Drug) $20.84
- Winlevi (Drug) $20.46
- EPSOLAY (Drug) $18.45
- Puraply (Medical Supply) $17.55
- REMICADE (Biological) $17.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.